Sulzmaier, Florian J <br/><br/>
RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics.  [electronic resource] 

 -  Oncotarget  Nov 2016 
 - 79869-79884 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.13084  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Brain Neoplasms--genetics<br/>Cell Adhesion--genetics<br/>Cell Line, Tumor<br/>Cell Movement--genetics<br/>Glioblastoma--genetics<br/>HEK293 Cells<br/>Humans<br/>Mice<br/>Molecular Targeted Therapy<br/>Neoplasm Invasiveness<br/>Ribosomal Protein S6 Kinases, 90-kDa--physiology